Search Login Register

cabergoline Summary

Description: also acts as prolactin antagonist

Also Known As: 1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea; 1-ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate; Cabaser; Cabaseril; Dostinex Show All >>

Networked: 663 relevant articles (112 outcomes, 129 trials/studies) for this Drug

Key Diseases for which cabergoline is Relevant

  1. Prolactinoma (Prolactinomas) : 31 outcomes 28 studies in 199 results
  2. Neoplasms (Cancer) : 16 outcomes 10 studies in 81 results
  3. Parkinson Disease (Parkinson's Disease) : 15 outcomes 34 studies in 123 results
  4. Hyperprolactinemia : 11 outcomes 16 studies in 117 results
  5. Acromegaly : 8 outcomes 9 studies in 33 results
Show All >>

Drugs Related to cabergoline

  1. Prolactin
  2. Dopamine Agonists (Dopamine Agonist)
  3. Bromocriptine (Parlodel)
  4. Levodopa (L Dopa)
  5. Octreotide (Sandostatin)
  6. Pergolide (Permax)
  7. Insulin-Like Growth Factor I (IGF-1)
  8. Gonadotropin-Releasing Hormone (GnRH)
  9. Risperidone (Risperdal Consta)
  10. BIM 23A760
Show All >>

Therapies Related to cabergoline

  1. Radiotherapy
  2. Activities of Daily Living (ADL)
  3. Oral Administration
  4. Subcutaneous Injections
  5. Craniotomy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.